Published in Science on March 29, 1991
Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol (2013) 2.28
Stage- and gender-specific proteomic analysis of Brugia malayi excretory-secretory products. PLoS Negl Trop Dis (2008) 2.06
A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis (2009) 1.89
Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling. PLoS Negl Trop Dis (2009) 1.88
Transmission of onchocerciasis in wadelai focus of northwestern Uganda has been interrupted and the disease eliminated. J Parasitol Res (2012) 1.76
Cryptococcus neoformans gene expression during experimental cryptococcal meningitis. Eukaryot Cell (2003) 1.49
Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl Trop Dis (2009) 1.32
Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis (2012) 1.23
Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan. Am J Trop Med Hyg (2013) 1.18
One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone. Am J Trop Med Hyg (2015) 1.07
Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan Africa. PLoS Negl Trop Dis (2014) 1.06
Interruption of transmission of Onchocerca volvulus in the Oaxaca focus, Mexico. Am J Trop Med Hyg (2010) 1.04
Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools. PLoS One (2013) 1.02
Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution. PLoS Negl Trop Dis (2014) 1.02
Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México. PLoS Negl Trop Dis (2013) 1.01
Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted. Am J Trop Med Hyg (2014) 1.01
Lack of active Onchocerca volvulus transmission in the northern Chiapas focus of Mexico. Am J Trop Med Hyg (2010) 0.97
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings. Parasit Vectors (2016) 0.97
Elimination of Onchocerca volvulus Transmission in the Huehuetenango Focus of Guatemala. J Parasitol Res (2012) 0.95
Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus. Parasit Vectors (2016) 0.93
Interruption of Onchocerca volvulus transmission in Northern Venezuela. Parasit Vectors (2013) 0.93
Analysis of genes expressed at the infective larval stage validates utility of Litomosoides sigmodontis as a murine model for filarial vaccine development. Infect Immun (2000) 0.92
Molecular cloning and characterization of recombinant parasite antigens for immunodiagnosis of onchocerciasis. J Clin Invest (1991) 0.92
Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus. Mem Inst Oswaldo Cruz (2014) 0.90
Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection. Clin Vaccine Immunol (2015) 0.86
Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes. PLoS Negl Trop Dis (2017) 0.84
Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasit Vectors (2016) 0.83
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus. PLoS Negl Trop Dis (2016) 0.82
Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus. Clin Diagn Lab Immunol (1996) 0.80
An Integrated Multiomics Approach to Identify Candidate Antigens for Serodiagnosis of Human Onchocerciasis. Mol Cell Proteomics (2015) 0.80
Brugia malayi adult low molecular weight IgG4-reactive antigens induce differential cytokine response in lymphocytes of endemic normal and asymptomatic microfilariae carriers in vitro. J Clin Immunol (2007) 0.77
Molecular cloning and characterization of a recombinant Histoplasma capsulatum antigen for antibody-based diagnosis of human histoplasmosis. J Clin Microbiol (1997) 0.77
Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes. Parasit Vectors (2016) 0.77
Metabolite profiling of infection-associated metabolic markers of onchocerciasis. Mol Biochem Parasitol (2017) 0.75
Preliminary evaluation of recombinant Onchocerca volvulus antigens for serodiagnosis of onchocerciasis. J Clin Microbiol (1993) 0.75
Comparison between the skin snip test and simple dot blot assay as potential rapid assessment tools for Onchocerciasis in the postcontrol era in Ghana. Clin Diagn Lab Immunol (2002) 0.75
Colorimetric tests for diagnosis of filarial infection and vector surveillance using non-instrumented nucleic acid loop-mediated isothermal amplification (NINA-LAMP). PLoS One (2017) 0.75
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ (1997) 4.76
The ecology of trachoma: an epidemiological study in southern Mexico. Bull World Health Organ (1985) 3.91
The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today (1997) 3.64
Malnutrition and parasitic helminth infections. Parasitology (2000) 3.53
Trachoma: evaluation of a new grading scheme in the United Republic of Tanzania. Bull World Health Organ (1987) 3.48
CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol (1999) 3.32
A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol (1992) 3.28
Age-standardization in epidemiological data. Int J Epidemiol (1994) 3.17
An inter-familial outbreak of Yersinia enterocolitica enteritis. N Engl J Med (1973) 3.14
Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet (1995) 3.06
Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci (1991) 2.89
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest (1993) 2.84
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69
The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology (1998) 2.63
The environment and the lens. Br J Ophthalmol (1980) 2.59
The global programme to eliminate lymphatic filariasis. Trop Med Int Health (2000) 2.58
The epidemiology of dry eye in Melbourne, Australia. Ophthalmology (1998) 2.58
Error in blood-pressure measurement due to incorrect cuff size in obese patients. Lancet (1982) 2.56
Dehalobacter restrictus gen. nov. and sp. nov., a strictly anaerobic bacterium that reductively dechlorinates tetra- and trichloroethene in an anaerobic respiration. Arch Microbiol (1998) 2.53
A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ (1986) 2.51
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Cataract: how much surgery do we have to do? Br J Ophthalmol (2000) 2.34
Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
Diabetic retinopathy: examination practices and referral patterns of general practitioners. Med J Aust (1996) 2.19
Actinomyces europaeus sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol (1997) 2.17
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol (1989) 2.16
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun (2001) 2.09
Immunological aspects of lymphatic filariasis and onchocerciasis in man. Trans R Soc Trop Med Hyg (1984) 2.05
Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis (2000) 2.05
Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol (1996) 2.03
Prevalence and causes of vision loss in central Tanzania. Int Ophthalmol (1991) 2.02
The excimer laser in Australia. Med J Aust (1992) 2.01
The epidemiology of cataract in Australia. Am J Ophthalmol (1999) 2.01
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
Age-specific causes of bilateral visual impairment. Arch Ophthalmol (2000) 1.98
Vision impairment predicts 5 year mortality. Br J Ophthalmol (2001) 1.98
Prevalence and risk factors of myopia in Victoria, Australia. Arch Ophthalmol (1999) 1.95
The epidemiology of trachoma in central Tanzania. Int J Epidemiol (1991) 1.93
Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet (1994) 1.92
Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol (1985) 1.91
Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology (2001) 1.90
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador. J Infect Dis (1994) 1.85
Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity (1997) 1.84
Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model. Bull World Health Organ (1996) 1.83
Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J Infect Dis (1988) 1.83
Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol (2005) 1.82
Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis (2000) 1.82
Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77
Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis (1998) 1.76
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol (1995) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
The prevalence of glaucoma among Eskimos of northwest Alaska. Arch Ophthalmol (1987) 1.72
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71
IgE responses in human filariasis. I. Quantitation of filaria-specific IgE. J Immunol (1981) 1.71
Senile lens changes and diabetes in two population studies. Am J Ophthalmol (1981) 1.69
Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol (1994) 1.69
Interferon-gamma in the management of infectious diseases. Ann Intern Med (1995) 1.68
Tropical medicine. BMJ (2000) 1.67
Assignment of Actinomyces pyogenes-like (CDC coryneform group E) bacteria to the genus Actinomyces as Actinomyces radingae sp. nov. and Actinomyces turicensis sp. nov. Lett Appl Microbiol (1995) 1.66
The effect of prescription eyewear on ocular exposure to ultraviolet radiation. Am J Public Health (1986) 1.65
International ophthalmology strategic plan to preserve and restore vision-vision for the future. Am J Ophthalmol (2001) 1.65
The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64
The ocular dose of ultraviolet radiation from sunlight exposure. Photochem Photobiol (1985) 1.64
Primary identification of Aureobacterium spp. isolated from clinical specimens as "Corynebacterium aquaticum". J Clin Microbiol (1994) 1.64
Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology (1993) 1.63
The remarkable difference between surface and step atoms in the magnetic anisotropy of two-dimensional nanostructures. Nat Mater (2003) 1.62
The effect of early cataracts on glare and contrast sensitivity. A pilot study. Arch Ophthalmol (1992) 1.61
Water availability and trachoma. Bull World Health Organ (1989) 1.61
Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens. J Immunol (1979) 1.61
Genomic distribution and functional characterisation of two distinct and conserved Plasmodium falciparum var gene 5' flanking sequences. Mol Biochem Parasitol (2000) 1.58
Detection of hepatitis B virus DNA in tears by polymerase chain reaction. Arch Ophthalmol (1994) 1.57
Prevalence and predictors of undercorrected refractive errors in the Victorian population. Am J Ophthalmol (1999) 1.56
Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children. Am J Trop Med Hyg (1987) 1.55
The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene (2007) 1.55
Perforating ocular fishhook injury. Arch Ophthalmol (1992) 1.54
Schizophrenia, psychotropic medication, and cataract. Ophthalmology (1999) 1.54
Simple differential detection of Entamoeba histolytica and Entamoeba dispar in fresh stool specimens by sodium acetate-acetic acid-formalin concentration and PCR. J Clin Microbiol (1997) 1.53
A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis (2000) 1.53
Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis. Ann Trop Med Parasitol (2002) 1.53
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J Infect Dis (1991) 1.52
Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J Infect Dis (1997) 1.52
High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51
Epidemiology of ocular trauma in Australia. Ophthalmology (1999) 1.50
Proposal of six new species in the genus Aureobacterium and transfer of Flavobacterium esteraromaticum Omelianski to the genus Aureobacterium as Aureobacterium esteraromaticum comb. nov. Int J Syst Bacteriol (1993) 1.50
Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis (1991) 1.49
Pseudoexfoliation syndrome in Australian adults. Am J Ophthalmol (2000) 1.48